Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial on the Safety and Efficacy of C1 Inhibitor for the Acute Management of Subarachnoid Hemorrhage

NCT06359782 is registered in ClinicalTrials.gov with Haaglanden Medical Centre as lead sponsor.

NCT NCT06359782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06359782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial on the Safety and Efficacy of C1 Inhibitor for the Acute Management of Subarachnoid Hemorrhage
Lead sponsor
Haaglanden Medical Centre
Phase
Phase 2
Overall status
Recruiting
Start date
November 4, 2024
Completion date
March 31, 2027
Enrollment
128 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

subarachnoid hemorrhage, aneurysmal